Outlook Therapeutics, Inc. (OTLK) stock
OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.39−0.01 (-2.74%)
Close on Nov 20, 2026Market cap $94.94MP/E –Yield –
Outlook Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Outlook Therapeutics's market cap was $89.99M on Nov 11, 2026, against $96.46M a year earlier. Over the last 5 years it ranged from $13.29M to $446.60M, with a median of $124.92M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $89.99M | +5.7% |
| 2025 | Dec 31, 2025 | $85.14M | +88.4% |
| 2024 | Dec 31, 2024 | $45.18M | -55.9% |
| 2023 | Dec 29, 2023 | $102.54M | -58.2% |
| 2022 | Dec 30, 2022 | $245.50M | +2.3% |
| 2021 | Dec 31, 2021 | $239.99M | +45.1% |
| 2020 | Dec 31, 2020 | $165.34M | +879.5% |
| 2019 | Dec 31, 2019 | $16.88M | -53.3% |
| 2018 | Dec 31, 2018 | $36.11M | +11.4% |
| 2017 | Dec 29, 2017 | $32.41M | -52.8% |
| 2016 | Dec 30, 2016 | $68.64M | – |
See a number that looks wrong?